Correction: Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.

Correction: Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma. Clin Cancer Res. 2018 Jan 15;24(2):500-501 Authors: PMID: 29339354 [PubMed - in process]
Source: Clinical Cancer Research - Category: Cancer & Oncology Tags: Clin Cancer Res Source Type: research